Task: Answer the multiple-choice question.
Question: Which drug exhibits a 16.472% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1ccc(S(=O)(=O)Nc2nnc(C3CCCCC3)s2)cc1
b.) COc1cc(-c2ccc3sc(-c4ccsc4)c(C#CCO)c3c2)cc(OC)c1OC
Answer: b. COc1cc(-c2ccc3sc(-c4ccsc4)c(C#CCO)c3c2)cc(OC)c1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(-c2ccc3sc(-c4ccsc4)c(C#CCO)c3c2)cc(OC)c1OC
COc1cc(-c2ccc3sc(-c4ccsc4)c(C#CCO)c3c2)cc(OC)c1OC
3-[2-thiophen-3-yl-5-(3,4,5-trimethoxyphenyl)-1-benzothiophen-3-yl]prop-2-yn-1-ol